KCT0007590招募中未知
A Noninterventional Exit Survey Study to Understand Meaningful Change in Subjects with Claudin (CLDN) 18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma who Discontinued Treatment in the SPOTLIGHT or GLOW Study
Astellas Korea0 个研究点目标入组 14 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- o Limit 至 o Limit（—）
- 性别
- All
入选标准
- •1. Institutional Review Board (IRB)/Independent Ethics Committee (IEC) approved written informed consent and privacy language as per national regulations (e.g., HIPAA Authorization for US sites) must be obtained from the subject or legally authorized representative (if applicable) prior to any study-related procedures.
- •2. Subjects who are within 30 days following the treatment discontinuation visit(s) (both study treatments) in the SPOTLIGHT (8951-CL-0301) or GLOW (8951-CL-0302) study.
排除标准
- •1. Subject has any concurrent disease, infection or comorbid condition that interferes with the ability of the subject to participate in the study, which places the subject at undue risk or complicates the interpretation of data in the opinion of the investigator.
研究者
相似试验
进行中（未招募）
不适用
A prospective non-interventional study to evaluate the effect of Triptorelin Embonate (Diphereline (Trademark TM) 11.25mg) on lower urinary tract symptoms (LUTS) in Australian prostate cancer patients.ocally advanced or metastatic prostate cancer with Lower Urinary Tract Symptoms (LUTS)Locally advanced or metastatic prostate cancer with Lower Urinary Tract Symptoms (LUTS)Cancer - ProstateRenal and Urogenital - Other renal and urogenital disordersACTRN12610000558022Ipsen Pty Ltd70
已完成
不适用
CAPTURE-IOType 2 Diabetes MellitusJPRN-jRCT1080224506ovo Nordisk Pharma Ltd.8,000
尚未招募
不适用
A non-interventional, prospective study to evaluate change in physical activity, relationship satisfaction and psychological well-being in patients with rheumatoid arthritis after introduction of the JAK inhibitor filgotinib and also in their partners.M06.8Other specified rheumatoid arthritisDRKS00032128Helios Fachklinik Vogelsang-Gommern, Rheumatologie40
尚未招募
不适用
Is variations in sleep pattern responsible for Aamavata(Rheumatoid Arthritis)CTRI/2021/02/030960All India Institute of Ayurveda
已完成
不适用
A non-interventional, post-marketing survey study of healthcare professionals based on their experience using a high-fiber enteral feeding.ConstipationJPRN-UMIN000048410estle Health Science Company, Nestle Japan Ltd.184